EDGAR BLECKER: Open Payments
NPI 1952388100 · SEBASTIAN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$670 in 25 payments from 13 companies in 2025. Trend: 2023 $1,465 · 2024 $491 · 2025 $670
Food & beverage: $670
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $258 |
| Amgen Inc. | 5 | $89 |
| Insmed, Inc. | 2 | $54 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| PFIZER INC. | 2 | $36 |
| Pulmonx Corporation | 2 | $35 |
| Eisai Inc. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: BREZTRI, AIRSUPRA, Arikayce, OTEZLA, TRELEGY ELLIPTA, VYNDAQEL, REPATHA, CHARTIS CATHETER.
Industry payments across FL — which companies pay providers there.
